Eyelid Diseases
4
Pipeline Programs
2
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Thea PharmaMA - Waltham
4 programs2
2
BlephasteamPhase 41 trial
BlephasteamPhase 41 trial
LT2420Phase 11 trial
Warming gogglesPhase 11 trial
Active Trials
NCT01086943Completed
+1 more trialsTrial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Thea PharmaBlephasteam
Thea PharmaBlephasteam
Thea PharmaWarming goggles
LumenisTriLift device
Clinical Trials (5)
Total enrollment: 30 patients across 5 trials
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
Start: Jun 2010Est. completion: Dec 2011
Phase 4Completed
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
Start: May 2010Est. completion: Dec 2010
Phase 4Completed
Clinical Safety Study on an Eyelid Warming Device to Evaluate the Eyelid and Cornea Temperature in Healthy Volunteers
Phase 1Completed
Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy
Start: Sep 2010Est. completion: Nov 2010
Phase 1Completed
Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects with Dry Eye Disease
Start: Aug 2023Est. completion: Sep 202430 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space